SCHEMBL7420892

SCHEMBL7420892

CC1CC(=O)N(OCC(=O)C(CC(=O)O)NC(=O)OCc2ccccc2)C1(C)C

nearest known ligand 0.65

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CASP1 P29466 20/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7409742 0.80 CASP1 (0.74) CASP1
SCHEMBL7414944 0.79 CASP1 (1.00) CASP1
SCHEMBL7437239 0.78 CASP1 (0.71) CASP1
SCHEMBL8055389 0.77 CASP1 (0.67) CASP1
SCHEMBL7411874 0.77 CASP1 (0.70) CASP1
SCHEMBL7416865 0.76 CASP1 (1.00) CASP1
SCHEMBL7416411 0.76 CASP1 (0.66) CASP1
SCHEMBL7448796 0.75 CASP1 (1.00) CASP1
SCHEMBL7434497 0.75 CASP1 (0.65) CASP1
SCHEMBL7449130 0.75 CASP1 (0.69) CASP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2001019373-A2 METHODS AND COMPOSITIONS FOR MODULATING RESPONSIVENESS TO CORTICOSTEROIDS BASF AKTIENGESELLSCHAFT (DE) 2001-03-22 WO disclosed
EP-0998300-A1 METHODS AND COMPOSITIONS FOR MODULATING RESPONSIVENESS TO CORTICOSTEROIDS BASF AKTIENGESELLSCHAFT (DE) 2000-05-10 EP disclosed
US-5919790-A ANTIINFLAMMATORY AGENT; THERAPY FOR STROKE, SEPTIC SHOCK;ALZHEIMER*S DISEASE WARNER-LAMBERT COMPANY (US) 1999-07-06 US disclosed
WO-1998041232-A2 COMPOSITIONS FOR MODULATING RESPONSIVENESS TO CORTICOSTEROIDS BASF AKTIENGESELLSCHAFT (DE) 1998-09-24 WO disclosed